The Registry of Toxic Effects of Chemical Substances
Hydrogen peroxide, 90% RTECS #: MX0900000
CAS #: 7722-84-1
The Registry of Toxic Effects of Chemical Substances
Hydrogen peroxide, 90% |
| UPDATE: February 2005 | MW: 34.02 | MF: H2O2 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
1 mg
|
severe
|
JTPAE7 29,308,2001
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
ovary
|
1 mmol/L
|
CALEDQ 5,199,1978
|
cytogenetic analysis
|
hamster
lung
|
100 µmol/L
|
IDZAAW 56,1,1981
|
cytogenetic analysis
|
hamster
embryo
|
100 µmol/L
|
IDZAAW 56,1,1981
|
cytogenetic analysis
|
hamster
fibroblast
|
250 mg/L
|
ESKHA5 (96),55,1978
|
cytogenetic analysis
|
mouse
Ascites tumor
|
10 mmol/L
|
MUREAV 4,385,1967
|
cytogenetic analysis
|
mouse
embryo
|
10 µmol/L
|
IDZAAW 56,1,1981
|
DNA adduct
|
hamster
embryo
|
0.9 µmol/L/1 hour
|
MUREAV 563,35,2004
|
DNA damage
|
Bacillus subtilis
|
50 mmol/L
|
BBACAQ 155,476,1968
|
DNA damage
|
cattle
other cell types
|
25 µmol/L
|
MUREAV 240,35,1990
|
DNA damage
|
Escherichia coli
|
0.1 µmol/plate/2 hour
|
MUREAV 535,171,2003
|
DNA damage
|
hamster
ovary
|
20 µmol/L
|
MUREAV 299,95,1993
|
DNA damage
|
hamster
lung
|
353 µmol/L
|
NATUAS 282,318,1979
|
DNA damage
|
hamster
lung
|
100 mmol/L/1 hour
|
MUTAEX 17,45,2002
|
DNA damage
|
hamster
lung
|
200 µmol/L/24 hour
|
ARTODN 75,604,2001
|
DNA damage
|
hamster
ovary
|
200 µmol/L/5 minute
|
MUREAV 560,41,2004
|
DNA damage
|
human
fibroblast
|
28 µmol/L
|
BBACAQ 781,56,1984
|
DNA damage
|
human
other cell types
|
100 µmol/L
|
CNREA8 45,2522,1985
|
DNA damage
|
human
lymphocyte
|
100 µmol/L
|
JCINAO 77,1312,1986
|
DNA damage
|
human
leukocyte
|
20 µmol/L
|
MUREAV 265,255,1992
|
DNA damage
|
human
lung
|
300 µmol/L/1 hour
|
MUREAV 515,99,2002
|
DNA damage
|
human
other cell types
|
100 µmol/L/3 hour
|
MUTAEX 16,439,2001
|
DNA damage
|
human
other cell types
|
10 µmol/L/15 minute
|
MUREAV 519,151,2002
|
DNA damage
|
human
lymphocyte
|
0.1 mmol/L/5 minute
|
MUREAV 508,157,2002
|
DNA damage
|
human
lymphocyte
|
0.1 mmol/L/1 hour
|
MUREAV 535,25,2003
|
DNA damage
|
human
other cell types
|
0.1 mmol/L/1 hour
|
MUREAV 535,25,2003
|
DNA damage
|
human
other cell types
|
0.375 mmol/L/5 minute
|
MUREAV 526,19,2003
|
DNA damage
|
human
lymphocyte
|
0.1 mmol/L/30 minute
|
TCMUD8 20,11,2000
|
DNA damage
|
human
other cell types
|
10 mmol/L/10 minute
|
MUREAV 537,1,2003
|
DNA damage
|
human
sperm
|
80 µmol/L/1 hour
|
MUREAV 544,173,2003
|
DNA damage
|
human
lymphocyte
|
1 µmol/L/2 hour
|
TOSCF2 72,283,2003
|
DNA damage
|
mammal (species unspecified)
lymphocyte
|
600 µmol/L
|
DECRDP 8,1,1982
|
DNA damage
|
mouse
other cell types
|
100 µmol/L
|
JCINAO 77,1312,1986
|
DNA damage
|
mouse
other cell types
|
1 µmol/L
|
CRNGDP 4,1507,1983
|
DNA damage
|
mouse
lymphocyte
|
2 mmol/L
|
MUREAV 203,155,1988
|
DNA damage
|
mouse
other cell types
|
0.1 mmol/L/1 hour
|
MUREAV 535,25,2003
|
DNA damage
|
mouse
other cell types
|
200 µmol/L/1 hour (-enzymatic activation step)
|
MUREAV 541,9,2003
|
DNA damage
|
mouse
fibroblast
|
25 µmol/L/15 minute
|
MUREAV 531,165,2003
|
DNA damage
|
non-mammalian species
other cell types
|
0.4 mmol/L/1 hour
|
MUREAV 539,19,2003
|
DNA damage
|
non-mammalian species
other cell types
|
44 µmol/L/20 minute
|
MUREAV 542,15,2003
|
DNA damage
|
Neurospora crassa
|
50 µmol/L
|
MUREAV 405,29,1998
|
DNA damage
|
other fish
other cell types
|
0.1 mmol/L/5 minute
|
MUREAV 534,165,2003
|
DNA damage
|
other microorganisms
|
1 mmol/L
|
MUREAV 368,235,1996
|
DNA damage
|
rat
other cell types
|
200 µmol/L
|
CRNGDP 20,629,1999
|
DNA damage
|
rat
liver
|
300 µmol/L/1 hour
|
MUREAV 515,99,2002
|
DNA damage
|
rat
other cell types
|
10 µmol/L/24 hour
|
ATSUDG 75,243,2001
|
DNA damage
|
salmon
embryo
|
5 µmol/L/1 hour
|
MUREAV 563,89,2004
|
DNA inhibition
|
human
other cell types
|
1,200 µmol/L
|
CNREA8 45,2522,1985
|
DNA inhibition
|
human
fibroblast
|
1 mg/L
|
CRNGDP 4,1317,1983
|
DNA inhibition
|
mouse
other cell types
|
40 µmol/L
|
JCINAO 77,1312,1986
|
DNA repair
|
Escherichia coli
|
14,630 µg/well/16 hour
|
CBINA8 15,219,1976
|
DNA repair
|
human
fibroblast
|
20 µmol/L/1 hour
|
MUREAV 513,159,2002
|
DNA repair
|
human
other cell types
|
10 mmol/L/10 minute
|
MUREAV 537,1,2003
|
DNA repair
|
Salmonella typhimurium
|
2 mmol/L/60 minute
|
MUREAV 502,11,2002
|
unscheduled DNA synthesis
|
human
fibroblast
|
1 mmol/L
|
CALEDQ 5,199,1978
|
unscheduled DNA synthesis
|
human
lung
|
600 µg/L
|
ENMUDM 5,177,1983
|
mutation in microorganisms
|
Bacillus subtilis
|
5 ppm (-enzymatic activation step)
|
MUREAV 95,191,1982
|
mutation in microorganisms
|
Bacillus subtilis
|
5 pph/15 minute
|
MUREAV 503,77,2002
|
mutation in microorganisms
|
Escherichia coli
|
5 pph (-enzymatic activation step)
|
AGACBH 4,286,1974
|
mutation in microorganisms
|
Escherichia coli
|
100 µg/plate/48 hour (+/-enzymatic activation step)
|
MUREAV 539,29,2003
|
mutation in microorganisms
|
Haemophilus influenzae
|
800 µmol/L (-enzymatic activation step)
|
MUREAV 30,9,1975
|
mutation in microorganisms
|
Neurospora crassa
|
210 mmol/L/30 minute (-enzymatic activation step)
|
PNASA6 35,581,1949
|
mutation in microorganisms
|
other microorganisms
|
6 ppm/1 hour- continuous (-enzymatic activation step)
|
JOBAAY 54,767,1947
|
mutation in microorganisms
|
other microorganisms
|
6 ppm (-enzymatic activation step)
|
POASAD 34,114,1953
|
mutation in microorganisms
|
Salmonella typhimurium
|
6 µg/plate (-enzymatic activation step)
|
ABCHA6 44,1989,1980
|
mutation in microorganisms
|
Salmonella typhimurium
|
200 µg/plate/72 hour (-enzymatic activation step)
|
TOLED5 116,189,2000
|
mutation in microorganisms
|
Salmonella typhimurium
|
1.87 mg/plate/30 minute
|
MUREAV 535,171,2003
|
mutation in microorganisms
|
Salmonella typhimurium
|
25 µg/plate/48 hour (+/-enzymatic activation step)
|
MUREAV 539,29,2003
|
mutation in microorganisms
|
Salmonella typhimurium
|
500 µg/plate/66 hour (-enzymatic activation step)
|
EMMUEG 40,63,2002
|
mutation in microorganisms
|
Salmonella typhimurium
|
34,000 ng/plate/72 hour
|
MUREAV 542,49,2003
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
10 mg/L (-enzymatic activation step)
|
MUREAV 33,147,1975
|
mutation in microorganisms
|
Schizosaccharomyces pombe
|
2,820 mmol/L (-enzymatic activation step)
|
ADWMAX -,193,1962
|
micronucleus test
|
hamster
embryo
|
5 mg/L/4 hour (-enzymatic activation step)
|
MUREAV 561,153,2004
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
5 pph
|
AGACBH 4,286,1974
|
mutation in mammalian somatic cells
|
hamster
lung
|
10 µmol/L
|
CRNGDP 10,1055,1989
|
mutation in mammalian somatic cells
|
monkey
kidney
|
7 mmol/L
|
CRNGDP 11,283,1990
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
18,600 nmol/L
|
MUTAEX 3,193,1988
|
morphological transform
|
hamster
embryo
|
2,500 µg/L
|
MUREAV 356,85,1996
|
morphological transform
|
mouse
embryo
|
20 µmol/L
|
CRNGDP 10,1055,1989
|
morphological transform
|
rat
liver
|
100 µmol/L/7 week
|
MOCAE8 30,209,2001
|
other mutation test systems
|
Bacillus subtilis
|
100 µmol/L
|
MUREAV 4,517,1967
|
other mutation test systems
|
Escherichia coli
|
100 µmol/L
|
MUREAV 203,81,1988
|
other mutation test systems
|
human
other cell types
|
1,200 µmol/L
|
CNREA8 45,2522,1985
|
other mutation test systems
|
Salmonella typhimurium
|
45 mg/L
|
MUREAV 192,239,1987
|
phage inhibition capacity
|
Escherichia coli
|
500 ng/well
|
MUREAV 260,349,1991
|
sister chromatid exchange
|
hamster
lung
|
40 µmol/L
|
MUREAV 174,21,1986
|
sister chromatid exchange
|
hamster
ovary
|
80 µmol/L
|
MUREAV 224,269,1989
|
specific locus test
|
Escherichia coli
|
2.5 mmol/L/10 minute
|
MUREAV 508,107,2002
|
specific locus test
|
Escherichia coli
|
1 µmol/L/4 hour
|
MUREAV 560,27,2004
|
specific locus test
|
mouse
kidney
|
65 µmol/L
|
MUREAV 503,69,2002
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 144 gm/kg/26 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Gastrointestinal: Tumors
GANNA2 75,17,1984
|
oral | mouse
toxic dose : 168 gm/kg/30 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Gastrointestinal: Tumors
GANNA2 75,17,1984
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | human
lowest published toxic concentration: 10 mg/m3
|
Skin: After topical application: Primary irritation
|
VCVN1* -,18,1998
|
inhalation | human
lowest published toxic concentration: 20 mg/m3
|
Peripheral Nerve and Sensation: Flaccid paralysis with appropriate anesthesia | Behavioral: Tetany Cardiac: Arrythmias (indlucing changes in conduction)
VCVN1* -,18,1998
|
inhalation | mammal (species unspecified)
lowest published toxic concentration: 60 mg/m3/4 hour
|
Skin: After topical application: Primary irritation
|
VCVN1* -,17,1998
|
inhalation | mouse
lowest published lethal concentration: 227 ppm
|
N/R
|
AEHLAU 4,327,1962
|
inhalation | rat
lethal concentration (50 percent kill): 2 gm/m3/4 hour
|
Lung, Thorax, or Respiration: Pulmonary emboli
|
GTPZAB 21(10),22,1977
|
inhalation | rat
lethal concentration (50 percent kill): 2,000 mg/m3
|
N/R
|
VCVN1* -,17,1998
|
intraperitoneal | mouse
lethal dose (50 percent kill): 880 mg/kg
|
N/R
|
VCVN1* -,17,1998
|
intravenous | dog
lowest published toxic dose: 0.3 mg/kg
|
Behavioral: Excitement | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVN1* -,17,1998
|
intravenous | horse, donkey
lowest published toxic dose: 40 µg/kg
|
Cardiac: Pulse rate increased without fall in BP | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,17,1998
|
intravenous | rabbit
lethal dose (50 percent kill): 15 gm/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
MRLR** #75,1951
|
intravenous | rabbit
lowest published lethal dose: 0.4 mg/kg
|
Behavioral: Tremor | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
VCVN1* -,17,1998
|
oral | mouse
lethal dose (50 percent kill): 2,000 mg/kg
|
N/R
|
VCVN1* -,17,1998
|
oral | rat
lethal dose (50 percent kill): 376 mg/kg
|
Gastrointestinal: Peritonitis | Blood: Pigmented or nucleated red blood cells Blood: Changes in leukocyte (WBC) count
STGNBT -,39,1999
|
oral | rat
lethal dose (50 percent kill): 4,050 mg/kg
|
N/R
|
VCVN1* -,17,1998
|
subcutaneous | mouse
lethal dose (50 percent kill): 1,072 mg/kg
|
N/R
|
GISAAA 48(6),28,1983
|
subcutaneous | rat
lethal dose (50 percent kill): 620 mg/kg
|
N/R
|
VCVN1* -,17,1998
|
skin | mammal (species unspecified)
lowest published toxic concentration: 110 mg/m3
|
Cardiac: Pulse rate increased without fall in BP | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVN1* -,17,1998
|
skin | mouse
lethal dose (50 percent kill): 1,072 mg/kg
|
N/R
|
VCVN1* -,17,1998
|
skin | mouse
lowest published toxic concentration: 10 pph
|
Vascular: Other changes
|
VCVN1* -,18,1998
|
skin | pig
lowest published lethal dose: 2 gm/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
MRLR** #75,1951
|
skin | rat
lethal dose (50 percent kill): 4,060 mg/kg
|
Lung, Thorax, or Respiration: Pulmonary emboli
|
GTPZAB 21(10),22,1977
|
skin | rat
lethal concentration (50 percent kill): 4,060 mg/m3
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Effect on specific coenzyme: Disturbed regulation
VCVN1* -,17,1998
|
skin | rabbit
lowest published lethal dose: 500 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
MRLR** #75,1951
|
skin | rabbit
lowest published lethal concentration: 15 pph
|
Eye: Lacrimation | Behavioral: Headache Lung, Thorax, or Respiration: Cough
VCVN1* -,18,1998
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | dog
lowest published toxic concentration: 7 ppm/6 hour/26 week- intermittent
|
Skin: After systemic exposure: Dermatitis, other | Skin and Appendages: Other: Hair
AMIHBC 10,319,1954
|
inhalation | mouse
lowest published toxic concentration: 57 ppm/6 hour/6 week- intermittent
|
Skin: After systemic exposure: Dermatitis, irritative | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
AMIHBC 10,319,1954
|
inhalation | rat
lowest published toxic concentration: 67 ppm/6 hour/6 week- intermittent
|
Skin: After systemic exposure: Dermatitis, irritative | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
AMIHBC 10,319,1954
|
inhalation | rat
lowest published toxic concentration: 10 mg/m3/5 hour/17 week- intermittent
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Monoamine oxidase Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
GTPZAB 21(10),22,1977
|
inhalation | rat
lowest published toxic concentration: 10 mg/m3/5 hour/8 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
|
VCVN1* -,18,1998
|
inhalation | rat
lowest published toxic concentration: 10 mg/m3/5 hour/17 week- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
VCVN1* -,18,1998
|
oral | rat
lowest published toxic dose: 8.75 mg/kg/25 week- continuous
|
Endocrine: Effect on menstrual cycle | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
VCVN1* -,19,1988
|
oral | rabbit
lowest published toxic dose: 8.75 mg/kg/25 week- continuous
|
Endocrine: Effect on menstrual cycle | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
VCVN1* -,19,1988
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 1 ppm
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Animal Carcinogen with Unknown
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Limited Evidence
|
IMEMDT 36,285,1985
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Limited Evidence
|
IMEMDT 71,671,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 36,285,1985
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 71,671,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 3
|
IMEMDT 71,671,1999
|
TOXICOLOGY REVIEW
|
|
MUREAV 566,99,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 544,179,2003
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: RED Completed
|
RBREV* -,330,1998
|
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 1 ppm (1.4 mg/m3)
|
DTLVS* 3,131,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 1 ppm (1.4 mg/m3)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 1 ppm (1.4 mg/m3)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 1 ppm (1.4 mg/m3)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 1 ppm (1.4 mg/m3)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 1 ppm (1.5 mg/m3), JAN1993
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 1 ppm (1.4 mg/m3), JAN1993
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 1 ppm (1.4 mg/m3), short term exposure limit 3 ppm (4.2 mg/m3), JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 1 ppm (1.5 mg/m3), JAN1993
|
Occupational Exposure Limit - GERMANY
|
MAK 1 ppm (1.4 mg/m3), JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 1 ppm (1.4 mg/m3), JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 1 ppm (1.4 mg/m3), JAN1993
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 1.4 mg/m3, 2003
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 1 ppm (1.4 mg/m3), JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 1 ppm (1.4 mg/m3, short term exposure limit 2 ppm (2.8 mg/m3), SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed Animal Carcinogen with Unknown
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed Animal Carcinogen with Unknown | ||||||||||||||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO HYDROGEN PEROXIDE-air
|
10 hour time-weighted average 1.0 ppm
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 38605; | Number of Industries 168; Total Number of Facilities 19,597; Number of Occupations 83; Total Number of Employees Exposed 422,227
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 38605 |
 ;Number of Industries 171; Total Number of Facilities 22,930; Number of Occupations 142; Total Number of Employees Exposed 1,006,752; Total Number of Female Employees Exposed 727,702 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as an industrial chemical, food and feed additive, flavor, packaging material
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8799
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
| ||||||
REFERENCES:
CODEN
|
|
REFERENCE
ABCHA6
|
Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International,
Tokyo 100-31, Japan) V.25- 1961-
|
ADWMAX
|
Abhandlungen der Deutschen Akademie der Wissenschaften zu Berlin, Klasse fuer Medizin.
(Berlin, Ger. Dem. Rep.) 1950-68. Discontinued.
|
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
AGACBH
|
Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010
Basel, Switzerland) V.1- 1969/70-
|
AMIHBC
|
AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54.
For publisher information, see AEHLAU.
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ATSUDG
|
Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz
Way, Secaucus, NJ 07094) No.1- 1978-
|
BBACAQ
|
Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1947-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CBINA8
|
Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1969-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
DECRDP
|
Drugs under Experimental and Clinical Research. (Bioscience Ediprint, Blvd. James-Fazy 13,
1201 Geneva 1, Switzerland) V.1- 1977-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
ESKHA5
|
Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei
Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886-
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GANNA2
|
Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher
information, see JJCREP.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
GTPZAB
|
Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see
MTPEEI
|
IDZAAW
|
Japanese Journal of Genetics. Idengaku Zasshi. (Genetics Soc. of Japan, 111 Tanida, Mishima,
Shizuoka-ken, Japan) V.1- 1921-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JCINAO
|
Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY
10021) V.1- 1924-
|
JOBAAY
|
Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC
20006) V.1- 1916-
|
JTPAE7
|
Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi-
shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988
|
MOCAE8
|
Molecular Carcinogenesis. (John Wiley & Sons, 605 Third Avenue, New York, NY 10158) V.1-
1988-
|
MRLR**
|
U.S. Army, Chemical Corps Medical Laboratories Research Reports. (Army Chemical Center,
Edgewood Arsenal, MD)
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NATUAS
|
Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
PNASA6
|
Proceedings of the National Academy of Sciences of the United States of America. (National
Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418)
V.1- 1915-
|
POASAD
|
Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of Science, c/o Executive
Secretary-Treasurer, Southwestern Oklahoma State Univ., Weatherford, OK 73096) V.1-
1910/1920-
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
STGNBT
|
"Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh
Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St.,
123182, Moscow, Russia, IzdAT 1999
|
TCMUD8
|
Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New
York, NY 10003) V.1- 1980-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
VCVN1*
|
"Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous
substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988.
|
| |